SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-018978
Filing Date
2020-10-06
Accepted
2020-10-06 08:33:01
Documents
13
Period of Report
2020-10-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41092
2 ex99-1.htm EX-99.1 18384
  Complete submission text file 0001493152-20-018978.txt   240999

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE crbp-20201006.xsd EX-101.SCH 3198
4 XBRL LABEL FILE crbp-20201006_lab.xml EX-101.LAB 35273
5 XBRL PRESENTATION FILE crbp-20201006_pre.xml EX-101.PRE 23154
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3650
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 201225626
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences